NATCO Pharma LimitedNSE: NATCOPHARM

Press Release Sep 30 2020

Sep 30, 2020 at 5:22 PM EDT · Issued by NATCO Pharma Limited

Filed with NSE · Sep 30, 2020 at 5:22 PM EDT

On 6ix: 6ix.com/news/press-release-sep-30-2020-9

Natco Pharma Limited has informed the Exchange regarding a press release dated September 30, 2020, titled "NATCO announces launch of breast cancer medicine Lapatinib Tablets in the U.S".

View Attachment

6ix hasn’t read this filing yet.

NATCO Pharma Limited on 6ix

Earlier from NATCO Pharma

NATCO Pharma records INR 582.1 Crore consolidated revenue and INR 122.1 Crore of profit, after tax, for the First Quarter, FY2020-21Aug 13, 2020

Later from NATCO Pharma

Press Release Nov 12 2020Nov 12, 2020
Press Release Nov 13 2020Nov 13, 2020
NATCO Pharma receives Pomalidomide approval for US marketNov 16, 2020
Press Release Dec 17 2020Dec 17, 2020
NATCO Pharma launches anti blood clot tablet Rivaroxaban in IndiaDec 18, 2020

All NATCO Pharma news releases

Follow NATCO Pharma into a list and get an email when it puts out news.

Follow NATCO Pharma